Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
The role of platelet-derived microparticles in the progression of acute myeloid leukemia and their application in cancer nanotechnology
Bahar Yazdani; Fatemeh Yari; Saeed MohammadiShow moreShow less
1. Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran; 2. Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, IranShow moreShow less
Lipid nanoparticle platforms for p53-targeted cancer therapy
Ricky MadisonShow moreShow less
1. Royal College of Surgeons in Ireland (RCSI), Dublin, IrelandShow moreShow less
Targeted delivery of boron depots containing immune adjuvant to achieve efficient cancer therapy via a combination of BNCT and cancer vaccine
Shanhong Mao; Hong Hu; Luoxin Long; Jing Wang; Hanyu Wan; Jiatong Lv; Yuji Wang; Liangzhi Xie; Zhengfei Shao; Shan HuangShow moreShow less
1. School of light industry Science and engineering, Beijing Technology and Business university, Beijing, China; 2. School of Biomedical Engineering, Capital Medical University, Beijing, China; 3. School of Biological Science and Medical Engineering, Beihang University, Beijing, China; 4. School of Food and Health, Beijing Technology and Business University, Beijing, China; 5. School of Pharmaceutical Sciences, Capital Medical University, Beijing, China; 6. Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China; 7. Pharmaceuticals Division, Nkd Pharma Co., Ltd., Beijing, China; 8. Beijing Harmony Health Medical Diagnostics Co., Ltd., Beijing, ChinaShow moreShow less
Magnetically-guided hyaluronic acid-decorated PLGA nanoparticles for enhanced tumor selective doxorubicin delivery in triple-negative breast cancer
Seonmin Choi; Jawoo Lee; Hyeyoun Cho; Yoonho Hwang; Sanghyo Park; Yong-Heum Lee; Jaehong KeyShow moreShow less
1. Department of Biomedical Engineering, Yonsei University, Gangwon-do, Republic of KoreaShow moreShow less
Selaginella doederleinii –derived extracellular vesicle-like particles induce ferroptosis via the xCT/GPX4 axis and are associated with metabolic and gut microbiota alterations in hepatocellular carcinoma
Jingting Zhang; Tianhao Tong; Hongyao Chen; Zhibin Wang; Ling Wu; Jincheng Tang; Wei Peng; Renyi Yang; Puhua ZengShow moreShow less
1. Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, China; 2. Hunan Academy of Traditional Chinese Medicine, Institute of Traditional Chinese Medicine Oncology, Changsha, China; 3. Hunan Provincial Key Laboratory of Translational Medicine in Chinese Medicine, Hunan University of Chinese Medicine, Changsha, ChinaShow moreShow less
Nano-enabled delivery of natural products and combinatorial chemotherapy for triple-negative breast cancers: mechanisms, synergy, and translational challenges
Somaia T. Mansour; Wael MamdouhShow moreShow less
1. Department of Biological, Chemical and Global Health Sciences, The American University in Cairo (AUC), New Cairo, EgyptShow moreShow less
FAQ
How long does Cancer Nanotechnology take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for Cancer Nanotechnology. The fastest paper went from submission to acceptance in 56 days (Performance of chelating agent modulated Β-cyclodextrin coated zinc ferrite nanocarriers for 5-FU delivery and cytotoxicity in glioblastoma, received 2026-04-06, accepted 2026-06-01); the slowest took 258 days. The average is 101 days and the median is 92.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
